Autologous-cultured epithelium sheet for vitiligo vulgaris
- Conditions
- Vitiligo vulgaris
- Registration Number
- JPRN-jRCTb030200129
- Lead Sponsor
- ishikawa Ayaka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5
(1)Patients who are over 20 years old and obtain consent in writing.
(2) Patients with a diagnosis of vitiligo vulgaris who have little or no effect on at least a few standard treatments
(3) Patients with stable vitiligo that has not progressed within the past year and does not show obvious Koebner phenomenon
(1) Patients being treated for autoimmune diseases
(2) Patients who are systemically administered steroids (corticosteroids)
(3) Patients with skin malignancy, patients with suspected skin malignancy, or patients with a history of skin malignancy less than 5 years
(4) Pregnant women, lactating women, patients who may be pregnant, patients who wish to become pregnant during the study period
(5) Patients with severe heart disease
(6) Patients with severe liver disease
(7) End stage renal failure
(8) Patients with severe blood coagulation disorder
(9) Person with active infection
(10) Persons with mental illness
(11) HCV antibody, HBs antigen, HTLV-1 virus antibody or HIV antibody positive
(12) Patients with allergic symptoms in cattle and mice
(13)Patients with vitiligo area that cannot be covered with Specific Cell Products to be transplanted
(14)Other patients who are determined to be inappropriate for participation in this study by the person in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method